Pacira Pharmaceuticals, Inc. Reports First Quarter EXPAREL Revenues of $56.0 Million and First Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. VRTX
4. WMT
5. RXST
6. SPGI
7. RIVN
8. LMT
9. AGIO
10. BFH

Go back to Pacira Pharmaceuticals, Inc. Reports First Quarter EXPAREL Revenues of $56.0 Million and First Quarter 2015 Financial Results

Pacira Pharma (PCRX) Tops Q2 EPS by 7c

April 30, 2015 6:32 AM EDT

Pacira Pharma (NASDAQ: PCRX) reported Q2 EPS of $0.27, $0.07 better than the analyst estimate of $0.20. Revenue for the quarter came in at $58.3 million versus the consensus estimate of $61.1 million.

EXPAREL net product revenues were $56.0 million in the first quarter of 2015, compared to $34.4 million... More